Vimal Mehta, CEO and President, 10% Owner at BioXcel Therapeutics, Inc. (BTAI), sold 3,117 shares at $0.36 ($1K) on 2024-12-16, disclosed to the SEC on 2024-12-17.
Scheduled sale ($1k) by CEO and President, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.36 | 983 | $354 | 31.5% |
| 2 | $0.36 | 2,134 | $768 | 68.5% |
| Total | $0.36 avg | 3,117 | $1K | 100% |
| Filing → |
| BTAI | SELL | 2024-06-18 | $3K | — | Filing → |
| BTAI | SELL | 2024-04-08 | $14K | — | Filing → |
| BTAI | SELL | 2023-06-16 | $2.5M | — | Filing → |